Aju IB Investment

What Aju IB Investment does

Aju IB Investment Co., Ltd. (아주아이비투자 주식회사) is a Korean multi-stage venture capital and private equity firm founded in 1974, recognized as Korea's first VC and a first-generation PE house. The firm invests across the full development lifecycle through four specialized divisions: Venture Investment, Global Investment, Private Equity, and Accelerator, deploying capital into innovative Korean and overseas companies. Aju IB Investment manages 2.5+ trillion KRW (~$1.8B) in assets under management as of Q4 2025, has liquidated 46 funds since 2009 with an average IRR above 15%, and operates with a 28-person investment professional staff.

The firm's underlying platform is a multi-fund vehicle architecture spanning Korean-domiciled funds (e.g., the 250 billion KRW AJU Good Private Equity Fund, raised 2017) and overseas-anchored funds (e.g., the Solasta Nexus Frontier Tech Fund at ~50 billion KRW target). The U.S. platform is operated through wholly-owned subsidiary Solasta Ventures (Boston, established 2013; converted to U.S. corporation 2019) and Solasta Nexus, Inc. (Silicon Valley, incorporated 2024), enabling cross-border deal sourcing and portfolio support. There is no proprietary technology product or AI/ML capability disclosed at the firm level.

The business model is standard asset management: recurring management fees on AUM across multiple fund vintages, supplemented by episodic performance-based carried interest on successful exits (IPOs, M&A). Limited partner relationships are private, with fundraising conducted through direct institutional channels. The firm became a publicly listed entity on KOSDAQ in 2018, making it one of a small number of Korean VC/PE houses with public-market disclosure. Revenue model streams include fund management fees (subscription/recurring) and carried interest (performance-linked). Customer segments are innovative growth companies across all stages, segmented horizontally rather than by vertical.

Name

Aju IB Investment

Legal name

아주아이비투자 주식회사

Website

http://www.ajuib.co.kr

Company type

Public

Founded year

1974

Operating status

Operating

Headcount range

11–50 employees

Short description

Aju IB Investment is a Korean multi-stage venture capital and private equity firm founded in 1974, managing 2.5+ trillion KRW in AUM across venture, global, PE, and accelerator divisions, serving innovative Korean and overseas growth companies through Seoul, Boston, and Silicon Valley offices.

Ownership category

akta.pro rank

Product category

Venture Capital and Private Equity Investment Management

NAICS

Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Miscellaneous Financial Investment Activities (523999)

SIC

Investors, Nec (6799), Investment Advice (6282)

akta.pro primary industry

SBIC Venture Debt Funds (FSANAIAD)

akta.pro secondary industry

Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE)

Keywords

• Venture capital services
• Private equity management
• Multi-stage investment funds
• Alternative investment management
• Growth capital financing

Headquarters

HQ city

Yeoksamdong

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Fund Management Fees: Management fees charged on assets under management across the firm's multiple fund vehicles, including domestic and overseas investment funds.
2. Carried Interest (Performance Fees): Performance-based carried interest earned on successful fund exits, generating returns when portfolio companies achieve exits through IPO, M&A, or other liquidity events.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Aju IB Investment is a KOSDAQ-listed venture capital and private equity firm that manages multi-stage investment funds for innovative companies at any development stage—from early-stage startups to growth companies. It invests across sectors including AI robotics, healthcare/biotech, and frontier technology through dedicated domestic and foreign funds, with US operations executed via its wholly-owned subsidiary Solasta Ventures headquartered in Boston. The firm earns revenue through management fees on assets under management (over 2.5 trillion KRW as of Q4 2025) and performance-based carried interest from portfolio exits.

Product overview

AJU IB Investment operates as a multi-stage VC and PE investment firm, offering investment management services to innovative companies across all development stages. The company provides investment products through various named funds (AJU Good Private Equity Fund, AJU Growth & Healthcare Fund, AJU Life Science funds, Solasta Nexus Frontier Tech Fund), while its U.S. subsidiary Solasta Ventures handles overseas investments from Boston and Silicon Valley offices. The firm does not offer technology products but provides financial investment services, ESG-aligned investment strategies, and stewardship code compliance to its LP and shareholder investors.

Differentiator

Problem solved

Functional benefit

Brands

• Solasta Nexus Frontier Tech Fund: A fund targeting approximately 50 billion won to accelerate overseas investment expansion, with participation in Summer Robotics Series A funding.

Products and services

• Aju IB Investment Multi-Stage VC and PE Fund Management
• Solasta Ventures (US Subsidiary Investment Platform)
• AJU Good Private Equity Fund
• AJU Growth & Healthcare Fund
• AJU Life Science Overseas Expansion Platform Fund
• Aju Life Science 3.0 Venture Fund
• Solasta Nexus Frontier Tech Fund

Quantifiable outcome

• 46 fund liquidations with average IRR of over 15%
• +1 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Korea Investment Partners: Largest Korean VC/PE firm managing multi-trillion KRW AUM across venture, growth, and buyout strategies with extensive global LP base. Directly comparable to Aju IB on multi-stage Korean investing, US cross-border activity, and 100+ active portfolio companies.
• KB Investment: Korean VC/PE affiliate of KB Financial Group, the largest domestic financial conglomerate. Competes head-to-head with Aju in Korea venture and growth investing, with broader sector coverage and balance-sheet backing.
• DSC Investment: Active Korean early-to-growth-stage VC that has co-invested alongside Aju IB in Y Biologics and Arc Series A. Comparable on deal participation patterns, sector focus (biotech/healthcare), and stage coverage.
• Mirae Asset Venture Investment: Korean VC arm of Mirae Asset Financial Group, one of the largest domestic asset managers. Directly comparable multi-stage VC operating in Korean innovation sectors with similar AUM scale.
• LB Investment: Korean VC/PE firm focused on growth and pre-IPO investments, frequently co-invests with Aju IB in Korean startups. Comparable on stage focus (growth/pre-IPO), sector mix, and LP base.
• SBI Investment Korea: Subsidiary of Japan's SBI Holdings focused on Korean venture and growth investing. Has co-invested with Aju in Senix Biotech Series B; comparable on Asian cross-border deal participation and biotech/healthcare focus.
• Atinum Investment: Korean venture and growth-stage investor with comparable AUM and US footprint to Aju. Operates in similar Korean SME/innovation segments with overlapping deal sourcing.

Broad incumbents

• Andreessen Horowitz (a16z): Largest US venture firm (multi-stage) with global LP base and broad technology sector coverage. Comparable on multi-stage VC capability, US LP access, and growing portfolio of frontier-tech investments.
• General Atlantic: Global growth-equity firm with strong Asian presence and Seoul operations. Comparable to Aju on growth-stage investing, technology and healthcare sector focus, and US-Korea cross-border deal activity.

Emerging players

• Smilegate Investment: Korean VC arm of Smilegate Holdings with growing AUM and early-stage focus. Co-invests in Korean startups alongside firms like Aju IB; comparable on Korean VC landscape positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments188 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aju IB Investment